The following reports provide prescription drug use and expenditure information for the most prescribed individual drugs and therapeutic drug classes. Every quarter the year-to-date report is updated and a new set of quarterly reports is added.
For a given quarter, program expenditures and rebate receipts are reported (i.e. a cash flow model of reporting). The expenditure information is based on the paid dates of the claims. The rebate data is based on the dates on which the rebate payments were received. Rebate receipts for the same quarter as the reported expenditures may not be realized until at least one quarter later.
All reports are in PDF format unless otherwise indicated.